• SENSEX 73,055.43
    -193.96 (--0.26%)
  • BANKNIFTY 54,925.70
    -51.20 (--0.09%)
  • SBI
    950.75 900.80(%)
  • Cyient
    1,268.00 1,226.25(%)
  • NSE
    1,640.25 1,683.00(%)
  • JSW Energy
    440.25 428.00(%)
  • Voltas
    940.00 970.70(%)
  • Eternal
    317.50 344.75(%)
  • IndusInd Bank
    832.00 750.45(%)
  • Persistent Systems
    5,909.85 6,597.00(%)
  • Swiggy
    174.90 207.75(%)
  • Cupid
    302.45 45.40(%)
  • TCS
    2,624.75 3,336.70(%)
  • Infosys
    1,198.30 1,727.85(%)
  • Havells India
    1,003.65 1,015.20(%)
  • C P C L
    1,529.95 1,677.00(%)
  • Lenskart Solut.
    615.80 355.70(%)
  • Divi's Lab.
    8,800.00 5,648.00(%)
  • PC Jeweller
    17.08 7.45(%)
  • Steel Str. Wheel
    469.70 434.05(%)
  • Reliance Industries
    1,201.95 1,611.20(%)
  • Netweb Technol.
    4,238.00 2,942.45(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Ipca Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 3617.0
  • ISIN : INE571A01038
1,903.50 -15 (-0.80%)
  • As on 23 Oct 2026 (EOD)

  • Today’s Low

    1,884.20

  • Today’s High

    1,952.00

  • Open

    1,898.00

  • Perv Close

    1,918.90

  • 52W Low

    1,251.60

  • 52W High

    2,038.00

Key Indicators

  • P/E(TTM)

    38.13

  • Mar.Cap (₹Cr.)

    48,292.60

  • Div & Yield %

    0.32

  • Book Value(₹)

    314.51

  • Debt-Equity Ratio

    -0.80

  • AGM Date

    22-Oct-2026

  • EPS

    49.90

  • P/E Ratio

    38.13

Financials Ratios

  • Debt-Equity Ratio

    0.24

  • Mar.Cap (₹Cr.)

    48,292.60

  • RONW (%)

    8.69

  • ROCE (%)

    12.92

Score Board

  • Equity (₹ in Cr.)

    25.37

  • BV (₹)

    314.50

  • Sales( ₹ in Cr.)

    7,336.75

  • NP (in Cr.)

    1,135.98

  • NP Var(%)

    38.0

  • Div%

    600.0

  • CPS (₹)

    55.40

  • EPS (₹)

    44.80

  • Traded Value (₹ in Lakhs)

    48,273.57

  • 52 Week High

    2,038.00

  • 52 Week Low

    1,251.60

  • Price BSE

    1903.0

  • Price NSE

    1,904.00

  • Market Capital( in Cr.)

    48,273.57

  • P/C Ratio

    34.40

  • P/E Ratio

    42.50

  • Price Vs.BV

    44.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 7,336.75 6,677.92 6,166.46 5,814.62 5,438.30 5,139.16
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 7,336.75 6,677.92 6,166.46 5,814.62 5,438.30 5,139.16
Other Income 94.64 71.29 111.29 111.19 52.92 62.24
Stock Adjustments 60.06 -128.43 55.19 -104.09 126.00 170.73
Total Income 7,491.45 6,620.78 6,332.94 5,821.72 5,617.22 5,372.13
EXPENDITURE :            
Raw Materials 1,916.84 1,764.88 2,033.57 1,964.94 1,911.88 1,753.21
Power and Fuel Cost 250.97 235.60 253.33 277.21 237.44 201.48
Employee Cost 1,655.90 1,479.34 1,336.19 1,193.39 1,102.14 948.84
Other Manufacturing Expenses 385.83 367.61 356.81 311.74 279.03 225.25
Selling and Administration Expenses 1,077.02 953.42 846.95 812.67 612.89 551.23
Miscellaneous Expenses 358.43 503.13 314.87 236.31 179.67 113.31
Employee Benefit Expenses 1,655.90 1,479.34 1,336.19 1,193.39 1,102.14 948.84
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 5,644.99 5,303.98 5,141.72 4,796.26 4,323.05 3,793.32
Operating Profit 1,846.46 1,316.80 1,191.22 1,025.46 1,294.17 1,578.81
Interest 45.46 65.06 122.58 46.34 10.41 11.13
Gross Profit 1,801.00 1,251.74 1,068.64 979.12 1,283.76 1,567.68
Depreciation 268.87 251.97 246.48 228.63 209.65 187.72
Profit Before Tax 1,532.13 999.77 822.16 750.49 1,074.11 1,379.96
Current Tax 402.12 340.90 288.01 223.95 197.28 244.98
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -2.51 8.11 3.74 20.84 16.46 -5.79
Reported Net Profit 1,132.52 650.76 530.41 505.70 860.37 1,140.77
Extraordinary Items -3.46 -169.55 -69.52 17.51 7.86 8.34
Adjusted Net Profit 1,135.98 820.31 599.93 488.19 852.51 1,132.43
Adjustment below Net Profit 3.35 -4.92 -1.39 -2.05 1.15 -0.16
P & L Balance brought forward 5,501.16 4,956.80 4,478.52 4,076.35 3,316.31 2,277.18
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 50.74 101.48 50.74 101.48 101.48 101.48
P & L Balance carried down 6,586.29 5,501.16 4,956.80 4,478.52 4,076.35 3,316.31
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 600.00 400.00 400.00 400.00 400.00 400.00
Dividend Per Share(Rs) 6.00 4.00 4.00 4.00 4.00 8.00
Earnings Per Share-Unit Curr 44.64 25.65 20.91 19.93 33.91 89.93
Earnings Per Share(Adj)-Unit Curr 44.64 25.65 20.91 19.93 33.91 44.97
Book Value 314.52 271.64 250.24 231.66 215.84 374.67
Book Value(Adj)-Unit Curr 314.52 271.64 250.24 231.66 215.84 187.34

Shareholding Pattern

  • Promoter Group

    44.72%

  • Public Share Holding

    55.28%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 95,423,418 37.61 95,423,418 5
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 18,044,054 7.11 18,044,054 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 113,467,472 44.72 113,467,472 14
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 813,281 0.32 813,281 2
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 2,130 0.00 130 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 8,000 0.00 8,000 1
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 29,233,718 11.52 29,233,718 269
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 8,000 0.00 0 1
Insurance Companies 12,069,568 4.76 12,069,568 10
Mutual Funds / UTI 78,817,748 31.07 78,813,748 31
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,136,717 0.45 1,136,717 24
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 122,089,162 48.12 122,075,162 340
2] Non Institution
Bodies Corporate 973,278 0.38 969,278 578
Clearing Members 105,593 0.04 105,593 32
Directors of their Relatives 43,700 0.02 43,700 2
Employees 23,000 0.01 0 10
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 931,856 0.37 929,864 2,905
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 686,514 0.27 684,514 1,346
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 0 0.00 0 0
Individuals holding nominal share capital up to Rs. 1 lakh 14,514,059 5.72 13,929,659 85,249
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 22,329 0.01 22,329 9
Others 820,313 0.32 820,313 2
Sub Total 18,147,584 7.15 17,532,192 90,160
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 253,704,218 100.00 253,074,826 90,514

Company Background

Ipca Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Ipca Laboratories Ltd
  • BSE Code : 3617.0
  • ISIN : INE571A01038

  • Incorporation Year

    1949

  • Registered Office

    48 Kandivli Industrial Estate
    Kandivli (West), Mumbai,
    Maharashtra-400067

  • Telephone

    91-22-66474444

  • FAX

    91-22-28686613

  • Chairman

    Premchand Godha

  • Managing Director

    A K Jain

  • Company Secretary

    Harish P Kamath

  • Auditor

    NVC & Associates LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Ipca Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Ipca Labs. 1,902.75 7,431.39 7,336.75 38.82 19.48
Abbott India 25,393.50 7,217.19 6,929.05 33.42 43.78
Astrazeneca Phar 6,098.65 2,304.07 2,275.58 89.88 27.86
Glaxosmi. Pharma 2,434.70 3,932.76 3,790.20 38.89 58.17
Novartis India 1,686.70 393.10 354.33 42.59 15.94
Cipla 1,329.90 20,102.60 18,979.95 34.95 13.88
Bliss GVS Pharma 640.25 773.53 729.81 59.50 12.51
Amrutanjan Healt 495.80 520.13 502.55 26.56 24.16
Fermenta Biotec. 457.40 474.15 450.25 21.35 18.77
Guj. Themis Bio. 355.10 168.25 165.82 94.95 18.05
Ambalal Sarabhai 36.28 19.52 3.94 67.19 6.77